Novartis AG (NVS)
153.81
-0.84
(-0.54%)
USD |
NYSE |
Aug 28, 16:00
152.80
-1.01
(-0.66%)
Pre-Market: 07:35
Novartis Free Cash Flow : 14.99B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.99B |
| March 31, 2026 | 16.05B |
| December 31, 2025 | 15.32B |
| September 30, 2025 | 17.15B |
| June 30, 2025 | 16.89B |
| March 31, 2025 | 14.85B |
| December 31, 2024 | 13.80B |
| September 30, 2024 | 12.51B |
| June 30, 2024 | 11.72B |
| March 31, 2024 | 10.25B |
| December 31, 2023 | 11.71B |
| September 30, 2023 | 13.58B |
| June 30, 2023 | 13.31B |
| March 31, 2023 | 13.80B |
| December 31, 2022 | 12.02B |
| September 30, 2022 | 11.29B |
| June 30, 2022 | 11.24B |
| March 31, 2022 | 11.57B |
| December 31, 2021 | 12.04B |
| September 30, 2021 | 12.18B |
| June 30, 2021 | 10.33B |
| March 31, 2021 | 10.33B |
| December 31, 2020 | 11.07B |
| September 30, 2020 | 10.91B |
| June 30, 2020 | 12.37B |
| Date | Value |
|---|---|
| March 31, 2020 | 11.53B |
| December 31, 2019 | 11.31B |
| September 30, 2019 | 11.52B |
| June 30, 2019 | 10.76B |
| March 31, 2019 | 11.55B |
| December 31, 2018 | 11.61B |
| September 30, 2018 | 10.99B |
| June 30, 2018 | 10.90B |
| March 31, 2018 | 10.44B |
| December 31, 2017 | 9.904B |
| September 30, 2017 | 10.51B |
| June 30, 2017 | 9.076B |
| March 31, 2017 | 8.751B |
| December 31, 2016 | 8.596B |
| September 30, 2016 | 7.787B |
| June 30, 2016 | 8.633B |
| March 31, 2016 | 8.314B |
| December 31, 2015 | 8.392B |
| September 30, 2015 | 9.721B |
| June 30, 2015 | 10.91B |
| March 31, 2015 | 11.03B |
| December 31, 2014 | 10.49B |
| September 30, 2014 | 9.848B |
| June 30, 2014 | 10.08B |
| March 31, 2014 | 9.194B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Roche Holding AG | 16.37B |
| AstraZeneca PLC | 8.051B |
| Johnson & Johnson | 22.61B |
| Eli Lilly & Co. | 13.56B |
| Merck & Co., Inc. | 16.06B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 5.888B |
| Cash from Investing (Quarterly) | -3.090B |
| Cash from Financing (Quarterly) | -2.031B |
| Free Cash Flow Per Share (Quarterly) | 2.680 |
| Free Cash Flow to Equity (Quarterly) | 3.114B |
| Free Cash Flow to Firm (Quarterly) | 5.483B |
| Free Cash Flow Yield | 5.06% |